Advertisement
Screener

Humacyte, Inc. (HUMA) Auditor

Humacyte, Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-27: Fiscal year end 2025-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Raleigh, North Carolina.
  • 2025-03-31: Fiscal year end 2024-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Raleigh, North Carolina.
  • 2024-03-28: Fiscal year end 2023-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Raleigh, North Carolina.
  • 2023-03-24: Fiscal year end 2022-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Raleigh, North Carolina.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-272025-12-31PricewaterhouseCoopers LLP238Raleigh, North CarolinaNo
2025-03-312024-12-31PricewaterhouseCoopers LLP238Raleigh, North CarolinaNo
2024-03-282023-12-31PricewaterhouseCoopers LLP238Raleigh, North CarolinaNo
2023-03-242022-12-31PricewaterhouseCoopers LLP238Raleigh, North CarolinaNo
2022-03-292021-12-31PricewaterhouseCoopers LLP238Raleigh, North CarolinaNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63